SCHEMBL15466547

SCHEMBL15466547

CCc1cccc2c3ccccc3n(CC)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
LMNA P02545 5/20 0.48
HTT P42858 4/20 0.48
MAPK1 P28482 3/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 7/20 0.47
MAPT P10636 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
HSD17B10 Q99714 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
HBB P68871 1/20 0.47
NPY5R Q15761 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
PGR P06401 2/20 0.45
POLB P06746 2/20 0.44
PKM P14618 1/20 0.44
RCE1 Q9Y256 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9986337 0.88 ALDH1A1 (0.49) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL30268631 0.86 ALDH1A1 (0.47) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL14208786 0.83 ALDH1A1 (0.59) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL29139893 0.82 ALDH1A1 (0.50) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL17885720 0.81 ALDH1A1 (0.53) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL1001712 0.81 LIPG (0.44) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL8178240 0.80 ALKBH5 (0.59) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL11702583 0.80 ALKBH5 (0.59) ALDH1A1LMNAHTTHPGDKDM4E
SCHEMBL16810886 0.79 MAPT (0.43) ALDH1A1LMNAHTTMAPK1HPGD
SCHEMBL8748389 0.79 NPY5R (0.42) ALDH1A1LMNAHTTMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10043978-B2 Organic semiconductor formulations FLEXTERRA, INC. (US) 2018-08-07 US disclosed
US-20170012208-A1 ORGANIC SEMICONDUCTOR FORMULATIONS USINVEST LLC 2017-01-12 US disclosed
US-20160380209-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-12-29 US disclosed
US-9293711-B2 Organic semiconductor formulations POLYERA CORPORATION (US) 2016-03-22 US disclosed
US-20140042369-A1 Organic Semiconductor Formulations USINVEST LLC 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380209-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALDH1A1 189/4885LMNA 1967/4885HTT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.